Portal de Periódicos da CAPES

Contemporary clinical management of oral squamous cell carcinoma

2011; Wiley; Volume: 57; Issue: 1 Linguagem: Inglês

10.1111/j.1600-0757.2011.00392.x

1600-0757

Richard Shaw, A. Pace‐Balzan, Chris Butterworth,

Head and Neck Surgical Oncology

Periodontology 2000Volume 57, Issue 1 p. 89-101 Contemporary clinical management of oral squamous cell carcinoma Richard J. Shaw, Richard J. ShawSearch for more papers by this authorAdrian Pace-Balzan, Adrian Pace-BalzanSearch for more papers by this authorChris Butterworth, Chris ButterworthSearch for more papers by this author Richard J. Shaw, Richard J. ShawSearch for more papers by this authorAdrian Pace-Balzan, Adrian Pace-BalzanSearch for more papers by this authorChris Butterworth, Chris ButterworthSearch for more papers by this author First published: 22 July 2011 https://doi.org/10.1111/j.1600-0757.2011.00392.xCitations: 16Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Barringer DA, Hutcheson KA, Sturgis EM, Kies MS, Lewin JS. Effect of induction chemotherapy on speech and swallowing function in patients with oral tongue cancer. Head Neck 2009: 31: 611– 617. 2 Bernier J, Bonner J, Vermorken JB, Bensadoun RJ, Dummer R, Giralt J, Kornek G, Hartley A, Mesia R, Robert C, Segaert S, Ang KK. Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol 2008: 19: 142– 149. 3 Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefèbvre JL. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 2005: 27: 843– 850. 4 Betka J. Distant metastases from lip and oral cavity cancer. ORL J Otorhinolaryngol Relat Spec 2001: 63: 217– 221. 5 Bocca E, Pignataro O, Oldini C, Cappa C. Functional neck dissection: an evaluation and review of 843 cases. Laryngoscope 1984: 94: 942– 945. 6 Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006: 354: 567– 578. 7 Bourhis J, Lapeyre M, Tortochaux J, Rives M, Aghili M, Bourdin S, Lesaunier F, Benassi T, Lemanski C, Geoffrois L, Lusinchi A, Verrelle P, Bardet E, Julieron M, Wibault P, Luboinski M, Benhamou E. Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. J Clin Oncol 2006: 24: 2873– 2878. 8 Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, Horiot JC, Le Maître A, Pajak TF, Poulsen MG, O’Sullivan B, Dobrowsky W, Hliniak A, Skladowski K, Hay JH, Pinto LH, Fallai C, Fu KK, Sylvester R, Pignon JP; Meta-Analysis of Radiotherapy in Carcinomas of Head and Neck (MARCH) Collaborative Group. Hyper fractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006: 368: 843– 854. 9 Brown JS, Blackburn TK, Woolgar JA, Lowe D, Errington RD, Vaughan ED, Rogers SN. A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with post-operative radiotherapy. Oral Oncol 2007: 43: 764– 773. 10 Brown JS, Griffith JF, Phelps PD, Browne RM. A comparison of different imaging modalities and direct inspection after periosteal stripping in predicting the invasion of the mandible by oral squamous cell carcinoma. Br J Oral Maxillofac Surg 1994: 32: 347– 359. 11 Brown JS, Lewis-Jones H. Evidence for imaging the mandible in the management of oral squamous cell carcinoma: a review. Br J Oral Maxillofac Surg 2001: 39: 411– 418. 12 Brown JS, Magennis P, Rogers SN, Cawood JI, Howell R, Vaughan ED. Trends in head and neck microvascular reconstructive surgery in Liverpool (1992–2001). Br J Oral Maxillofac Surg 2006: 44: 364– 370. 13 Byers RM. Modified neck dissection. A study of 967 cases from 1970 to 1980. Am J Surg 1985: 150: 414– 421. 14 Byers RM, Weber RS, Andrews T, McGill D, Kare R, Wolf P. Frequency and therapeutic implications of ‘skip metastases’ in the neck from squamous carcinoma of the oral tongue. Head Neck 1997: 19: 14– 19. 15 Califano J, van der RP, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996: 56: 2488– 2492. 16 Cancer Research UK. Trends in UK Cancer Incidence [WWW document]. Available at: http://info.cancerresearchuk.org/cancerstats/incidence/trends/ [accessed on 21 March 2011]. 17 Carter LM, Ogden GR. Oral cancer awareness of undergraduate medical and dental students. BMC Med Educ 2007: 7: 44. 18 Carter LM, Ogden GR. Oral cancer awareness of general medical and general dental practitioners. Br Dent J 2007: 203: E10– E19. 19 Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008: 26: 612– 619. 20 Chiesa F, Sala L, Costa L, Moglia D, Mauri M, Podrecca S, Andreola S, Marchesini R, Bandieramonte G, Bartoli C. Excision of oral leukoplakias by CO2 laser on an out-patient basis: a useful procedure for prevention and early detection of oral carcinomas. Tumori 1986: 72: 307– 312. 21 Conway DI. Each portion of fruit or vegetable consumed halves the risk of oral cancer. Evid Based Dent 2007: 8: 19– 20. 22 Conway DI, Brewster DH, McKinney PA, Stark J, McMahon AD, Macpherson LM. Widening socio-economic inequalities in oral cancer incidence in Scotland, 1976–2002. Br J Cancer 2007: 96: 818– 820. 23 Conway DI, Stockton DL, Warnakulasuriya KA, Ogden G, Macpherson LM. Incidence of oral and oropharyngeal cancer in United Kingdom (1990–1999) – recent trends and regional variation. Oral Oncol 2006: 42: 586– 592. 24 Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK; Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004: 350: 1937– 1944. 25 Davidson BJ, Kulkarny V, Delacure MD, Shah JP. Posterior triangle metastases of squamous cell carcinoma of the upper aerodigestive tract. Am J Surg 1993: 166: 395– 398. 26 Diaz EM Jr, Holsinger FC, Zuniga ER, Roberts DB, Sorensen DM. Squamous cell carcinoma of the buccal mucosa: one institution’s experience with 119 previously untreated patients. Head Neck 2003: 25: 267– 273. 27 Henk JM. Treatment of oral cancer by interstitial irradiation using iridium-192. Br J Oral Maxillofac Surg 1992: 30: 355– 359. 28 Institute of Alcohol Studies. Alcohol Consumption in the UK. St Ives, Cambridgeshire: Institute of Alcohol Studies, 2010. 29 Jefferis BJ, Manor O, Power C. Social gradients in binge drinking and abstaining: trends in a cohort of British adults. J Epidemiol Community Health 2007: 61: 150– 153. 30 Jefferis BJ, Power C, Manor O. Adolescent drinking level and adult binge drinking in a national birth cohort. Addiction 2005: 100: 543– 549. 31 Keith DJ, Ong TK, Martin IC. The role of thoracic computed tomography in staging newly-diagnosed oral squamous cell carcinoma. Br J Oral Maxillofac Surg 2006: 44: 198– 202. 32 Kissun D, Magennis P, Lowe D, Brown JS, Vaughan ED, Rogers SN. Timing and presentation of recurrent oral and oropharyngeal squamous cell carcinoma and awareness in the outpatient clinic. Br J Oral Maxillofac Surg 2006: 44: 371– 376. 33 La Vecchia C, Lucchini F, Negri E, Levi F. Trends in oral cancer mortality in Europe. Oral Oncol 2004: 40: 433– 439. 34 Lydiatt DD, Robbins KT, Byers RM, Wolf PF. Treatment of stage I and II oral tongue cancer. Head Neck 1993: 15: 308– 312. 35 McGregor IA. The temporal flap in intra-oral cancer: its use in repairing the post-excisional defect. Br J Plast Surg 1963: 16: 318– 335. 36 National Institute for Clinical Excellence. Improving Outcomes in Head and Neck Cancer. London: National Institute for Clinical Excellence, 2004. 37 Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 2005: 46: 1136– 1143. 38 Nieuwenhuis EJ, Pijpers R, Castelijns JA, Snow GB. Lymphoscintigraphic details of sentinel lymph node detection in 82 patients with squamous cell carcinoma of the oral cavity and oropharynx. Nucl Med Commun 2003: 24: 651– 656. 39 Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A’Hern RP, Sydenham MA, Emson M, Hall E. PARSPORT Trial Management Group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011: 12: 127– 136. 40 O’Brien CJ, Lauer CS, Fredricks S, Clifford AR, McNeil EB, Bagia JS, Koulmandas C. Tumor thickness influences prognosis of T1 and T2 oral cavity cancer – but what thickness? Head Neck 2003: 25: 937– 945. 41 Office for National Statistics. Cigarette Smoking: Slight Fall in Smoking Prevalence [WWW document]. Available at: http://www.statistics.gov.uk/cci/nugget.asp?id=866 [accessed on 8 March 2011]. 42 Pace-Balzan A, Shaw RJ, Butterworth C. Oral rehabilitation following treatment for oral cancer. Periodontol 2000 2011: 57: 102– 117. 43 Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005: 55: 74– 108. 44 Petti S. Lifestyle risk factors for oral cancer. Oral Oncol 2009: 45: 340– 350. 45 Pignon JP, Maitre AL, Maillard E, Bourhis J; on behalf of the MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009: 92: 4– 14. 46 Podd TJ, Carton AT, Barrie R, Dawes PK, Roberts JT, Stassen LF, Henderson R, Macleod RL, Piggot TA. Treatment of oral cancers using iridium-192 interstitial irradiation. Br J Oral Maxillofac Surg 1994: 32: 207– 213. 47 Posner M, Vermorken JB. Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer. Semin Oncol 2008: 35: 221– 228. 48 Rogers SN, Brown JS, Woolgar JA, Lowe D, Magennis P, Shaw RJ, Sutton D, Errington D, Vaughan D. Survival following primary surgery for oral cancer. Oral Oncol 2009: 45: 201– 211. 49 Roosaar A, Yin L, Johansson AL, Sandborgh-Englund G, Nyren O, Axell T. A long-term follow-up study on the natural course of oral leukoplakia in a Swedish population-based sample. J Oral Pathol Med 2007: 36: 78– 82. 50 Ross G, Shoaib T, Soutar DS, Camilleri IG, Gray HW, Bessent RG, Robertson AG, MacDonald DG. The use of sentinel node biopsy to upstage the clinically N0 neck in head and neck cancer. Arch Otolaryngol Head Neck Surg 2002: 128: 1287– 1291. 51 Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 1990: 66: 109– 113. 52 Shah JP, Johnson NW, Batsakis JG. Oral Cancer. London: Taylor & Francis Ltd, 2003. 53 Shaw RJ, Brown JS, Woolgar JA, Lowe D, Rogers SN, Vaughan ED. The influence of the pattern of mandibular invasion on recurrence and survival in oral squamous cell carcinoma. Head Neck 2004: 26: 861– 869. 54 Shaw RJ, Lowe D, Woolgar JA, Brown JS, Vaughan ED, Evans C, Lewis-Jones H, Hanlon R, Hall GL, Rogers SN. Extracapsular spread in oral squamous cell carcinoma. Head Neck 2010: 32: 714– 722. 55 Shaw RJ, McGlashan G, Woolgar JA, Lowe D, Brown JS, Vaughan ED, Rogers SN. Prognostic importance of site in squamous cell carcinoma of the buccal mucosa. Br J Oral Maxillofac Surg 2009: 47: 356– 359. 56 Shaw RJ, Sutton AF, Cawood JI, Howell RA, Lowe D, Brown JS, Rogers SN, Vaughan ED. Oral rehabilitation after treatment for head and neck malignancy. Head Neck 2005: 27: 459– 470. 57 Sobin LH, Witterkind C. UICC TNM Classification of Malignant Tumours, 6th edn. Chichester: Wiley, 2002. 58 Sturgis EM, Moore BA, Glisson BS, Kies MS, Shin DM, Byers RM. Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series. Head Neck 2005: 27: 748– 756. 59 Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woolgar JA. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2003: 32: 30– 34. 60 van den Brekel MW, Reitsma LC, Quak JJ, Smeele LE, van der Linden JC, Snow GB, Castelijns JA. Sonographically guided aspiration cytology of neck nodes for selection of treatment and follow-up in patients with N0 head and neck cancer. AJNR Am J Neuroradiol 1999: 20: 1727– 1731. 61 Vaughan ED. Functional outcomes of free tissue transfer in head and neck cancer reconstruction. Oral Oncol 2009: 45: 421– 430. 62 Vaughan ED, Bainton R, Martin IC. Improvements in morbidity of mouth cancer using microvascular free flap reconstructions. J Craniomaxillofac Surg 1992: 20: 132– 134. 63 Vermorken JB. Medical treatment in head and neck cancer. Ann Oncol 2005: 2: ii258– ii264. 64 Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL; EORTC 24971/TAX 323 Study Group. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007: 357: 1695– 1704. 65 Wiener E, Pautke C, Link TM, Neff A, Kolk A. Comparison of 16-slice MSCT and MRI in the assessment of squamous cell carcinoma of the oral cavity. Eur J Radiol 2006: 58: 113– 118. 66 Woolgar JA. Detailed topography of cervical lymph-note metastases from oral squamous cell carcinoma. Int J Oral Maxillofac Surg 1997: 26: 3– 9. 67 Woolgar JA. The topography of cervical lymph node metastases revisited: the histological findings in 526 sides of neck dissection from 439 previously untreated patients. Int J Oral Maxillofac Surg 2007: 36: 219– 225. 68 Yousem DM, Som PM, Hackney DB, Schwaibold F, Hendrix RA. Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology 1992: 182: 753– 759. 69 Yung KC, Piccirillo JF. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer. Arch Otolaryngol Head Neck Surg 2008: 134: 1045– 1049. Citing Literature Volume57, Issue1October 2011Pages 89-101 ReferencesRelatedInformation